Found: 11
Select item for more details and to access through your institution.
Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine.
- Published in:
- Journal of Biomedical Science, 2021, v. 28, n. 1, p. 1, doi. 10.1186/s12929-021-00759-x
- By:
- Publication type:
- Article
A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions.
- Published in:
- Journal of Biomedical Science, 2021, v. 28, n. 1, p. 1, doi. 10.1186/s12929-021-00729-3
- By:
- Publication type:
- Article
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies.
- Published in:
- Journal of Ovarian Research, 2024, p. 1, doi. 10.1186/s13048-023-01325-9
- By:
- Publication type:
- Article
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0285221
- By:
- Publication type:
- Article
NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2147, doi. 10.1007/s00262-020-02615-7
- By:
- Publication type:
- Article
Localization of Salmonella and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity.
- Published in:
- Journal of Biomedical Science, 2022, v. 29, n. 1, p. 1, doi. 10.1186/s12929-022-00841-y
- By:
- Publication type:
- Article
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0256937
- By:
- Publication type:
- Article
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227727
- By:
- Publication type:
- Article
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0305710
- By:
- Publication type:
- Article
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 6, p. 1263, doi. 10.1002/ijc.29106
- By:
- Publication type:
- Article
Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
- Published in:
- Head & Neck, 2016, v. 38, n. 4, p. 522, doi. 10.1002/hed.23912
- By:
- Publication type:
- Article